PLASMA LEUKEMIA INHIBITORY FACTOR, INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR LEVELS DURING CARDIOPULMONARY BYPASS WITH EXTRACORPOREAL-CIRCULATION
Y. Denizot et al., PLASMA LEUKEMIA INHIBITORY FACTOR, INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR LEVELS DURING CARDIOPULMONARY BYPASS WITH EXTRACORPOREAL-CIRCULATION, Cytokine, 10(4), 1998, pp. 303-306
In this study the authors assessed plasma leukaemia inhibitory factor
(LIF), interleukin 6 (IL-6) and soluble IL-6 receptor (sIL-6R) concent
rations in 28 patients undergoing coronary artery bypass graft (CABG)
with extracorporeal circulation (ECC), Plasma IL-6 levels increased du
ring ECC, reaching a 33-fold increase 6 h after surgery as compared to
pre-operative values. In contrast, plasma sIL-6R and LIF concentratio
ns did not vary significantly during cardiac surgery. Thus, LIF is not
implicated in the haematological changes and in the inflammatory synd
rome observed after CABG. Despite the fact that LIF and IL-6 exhibit s
everal common biological activities, the production of these two cytok
ines is differently regulated during cardiac surgery with ECC, Plasma
IL-6 levels increased during cardiac surgery while sIL-6R levels did n
ot changed, These data contrast with the decreased sIL-6R concentratio
ns with concomitantly high IL-6 levels in patients with sepsis syndrom
e suggesting that inflammatory reactions in sepsis and after cardiopul
monary bypass are triggered by different mechanisms. (C) 1998 Academic
Press Limited.